AMBALAL SARABHAI share price has zoomed 9% and is presently trading at Rs 61.6.
Meanwhile, the BSE HEALTHCARE index is at 44,284.8 (up 0.8%).
Among the top gainers in the BSE HEALTHCARE index today are Procter & Gamble Health (up 3.4%) and Dr. Reddys (up 2.1%).
Jubilant Pharmova (down 0.7%) and SUVEN PHARMACEUTICALS (down 0.6%) are among the top losers today.
Over the last one year, AMBALAL SARABHAI has moved up from Rs 36.5 to Rs 61.6, registering a gain of Rs 25.1 (up 68.7%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,089.2 to 44,284.8, registering a gain of 57.7% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 207.3%), SUVEN PHARMACEUTICALS (up 132.2%) and Glenmark Pharma (up 129.3%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 79,982.6 (up 0.6%).
The top gainers among the BSE Sensex today are HCl Tech. (up 3.1%) and Infosys (up 2.9%). The most traded stocks in the BSE Sensex are ITC and Infosys.
In the meantime, NSE Nifty is at 24,401.2 (up 0.8%). Trent and HCl Tech. are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 64,958.7 to 79,982.6, registering a gain of 15,023.9 points (up 23.1%).
AMBALAL SARABHAI net profit grew 118.2% YoY to Rs 7 million for the quarter ended June 2024, compared to a loss of Rs 39 million a year ago. Net sales rose 12.7% to Rs 407 million during the period as against Rs 361 million in April-June 2023.
For the year ended March 2024, AMBALAL SARABHAI reported 50.4% decrease in net profit to Rs 57 million compared to net profit of Rs 114 million during FY23. Revenue of the company grew 1.9% to Rs 1,736 million during FY24.
The current Price to earnings ratio of AMBALAL SARABHAI, based on rolling 12 month earnings, stands at 36.3.
Equitymaster requests your view! Post a comment on "AMBALAL SARABHAI Gains 9%; BSE HEALTHCARE Index Up 0.8%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!